S-1: Mitesco, Inc. Files for Resale of 15.1 Million Common Shares Amid Debt Restructuring
S-1 Filing
Mitesco, Inc. is registering 15,128,771 shares of common stock for resale by selling stockholders, as part of a debt restructuring and business realignment.
Summary
- Mitesco, Inc., a holding company, has filed a registration statement for the resale of up to 15,128,771 shares of its common stock.
- The shares are being offered by selling stockholders, including those who received shares in connection with the restructuring of over $12 million in financial obligations.
- The restructuring involved the cancellation or exchange of promissory notes, accounts payable, and preferred stock for common stock or newly created Series A Amortizing Convertible Preferred Stock.
- The company is not selling any securities in this offering and will not receive any proceeds from the sale of shares by the selling stockholders.
- Mitesco's current business operations focus on providing products, services, and technology through its subsidiaries, Centcore, LLC (datacenter services) and Vero Technology Ventures, LLC (investment and acquisition opportunities).
- The company is developing an A.I.-based sales automation tool called Robo Agent, expected to be available for initial users in Q3 of FY2025.
- Mitesco has instituted a new Advisory Board, compensating members with restricted common stock for their expertise.
- The company has converted over $25 million of its obligations, including senior securities, notes, and accounts payable, into restricted common stock and Series A Preferred stock.
- As of December 31, 2024, the company had cash and cash equivalents of approximately $3,000 and current liabilities of approximately $18.4 million.
- There is substantial doubt about the company's ability to continue as a going concern, dependent on raising capital and generating revenues.
- The company's common stock is traded on the Pink Market of the OTC under the symbol MITI, with a last reported sale price of $0.50 on March 31, 2025.
Sentiment
Score: 3
Explanation: The document presents a mixed picture, with positive aspects like debt restructuring and new business ventures, but significant concerns about financial stability and going concern status dominate, leading to a low sentiment score.
Positives
- The company has successfully restructured over $12 million in financial obligations.
- The formation of Centcore, LLC and Vero Technology Ventures, LLC provides new avenues for revenue generation.
- The development of the Robo Agent A.I. tool could provide a competitive advantage in the sales automation market.
- The establishment of an Advisory Board brings in expertise to guide the company's strategic decisions.
- The company has extinguished all FY2024 bridge notes.
Negatives
- The company has a limited operating history and may never become profitable.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company has identified weaknesses in its internal controls.
- The company has a history of losses and limited cash on hand.
- The company faces intense competition in the data services industry.
- The company has a number of legal situations involved with the winding down of its clinic business activities.
Risks
- The company may be unable to attract and retain sufficient numbers of qualified personnel.
- The company may become involved in legal proceedings.
- The company may not manage its strategy effectively.
- Rapid technological change in the industry presents significant risks and challenges.
- The company may need to raise additional capital which may not be available on acceptable terms or at all.
- The company may incur additional debt in the future which may contain restrictive covenants.
- Redemption of all shares of Series A Preferred Stock into Common Stock may lead to severe dilution of existing shares.
- Resales of the company's Common Stock in the public market by its stockholders as a result of this offering may cause the market price of its Common Stock to fall.
- If the company's information technology systems or data, or those of third parties upon which it relies, are or were compromised, or are perceived to have been compromised, the company could experience adverse consequences.
Future Outlook
The company intends to redeem the Series A Preferred shares using common stock for the foreseeable future and is actively reviewing potential early-stage cloud computing solution vendors.
Industry Context
The company operates in the intensely competitive data services industry, facing competition from larger, more established firms with greater resources.
Comparison to Industry Standards
- The company faces competition from in-house IT departments, traditional global IT systems integrators like Accenture and IBM, cloud service providers, regional managed service providers, and colocation providers like Equinix and CyrusOne.
- Many competitors have greater financial, technical, and marketing resources, larger global presence, larger customer bases, longer operating histories, greater brand recognition, and more established relationships in the industry than Mitesco.
Legal Proceedings
- The Company has a number of legal situations involved with the winding down of its clinic business activities.
- These include claims regarding certain construction contracts and cancellation of leases.
Related Party Transactions
- The Company entered into a debt-for-equity exchange agreement with Gardner Builders Holdings, LLC.
- On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC.
- On December 6, 2024, the Company entered into an Exclusive Source Code License agreement between AgingTopic, LLC and the Company where the Company has acquired, subject to certain payment milestones, the source code and business activities of AgingTopic, which constitutes substantially all of AgingTopics assets utilized in the creation of advertising revenue from blog postings. The entity that owns the business and source code is controlled by Ms. Amy Lance, the wife of Mack Leath.
Stakeholder Impact
- Shareholders may experience dilution due to the potential redemption of Series A Preferred Stock into Common Stock.
- The company's ability to continue as a going concern impacts all stakeholders, including employees, customers, suppliers, and creditors.
- The company's financial condition may affect its ability to meet its obligations to leaseholders and vendors.
Next Steps
- The company intends to redeem the Series A Preferred shares using common stock for the foreseeable future.
- The company is continuing an effort to negotiate a settlement of any remaining obligations to Gardner.
- The company is actively monitoring the effects these disruptions and increasing inflation could have on its operations.
Key Dates
| Date | Description |
|---|---|
| January 18, 2012 | Mitesco, Inc. was formed in the state of Delaware. |
| December 9, 2015 | Mitesco restructured operations and acquired Newco4pharmacy, LLC. |
| April 24, 2020 | The company changed its name to Mitesco, Inc. |
| April 25, 2020 | The Company entered an unsecured Promissory Note with Bank of America for a loan in the original principal amount of $460,400. |
| May 4, 2020 | The Company received the full amount of the loan proceeds on the Promissory Note with Bank of America. |
| June 24, 2021 | The company entered into an agreement to open an administrative office in St. Louis Park, Minnesota. |
| September 28, 2021 | The company entered into an agreement to open a clinic in Denver, Colorado. |
| January 7, 2022 | The Company entered into a debt-for-equity exchange agreement with Gardner Builders Holdings, LLC. |
| March 18, 2022 | The Company entered into a Securities Purchase Agreement with AJB Capital Investments, LLC. |
| April 6, 2022 | The Company entered into a Securities Purchase Agreement with Anson Investments Master Fund LP and Anson East Master Fund LP. |
| April 18, 2022 | The Company entered into a Securities Purchase Agreement with GS Capital Investments, LLC. |
| May 10, 2022 | The Company entered into a Securities Purchase Agreement with Kishon Investments, LLC. |
| May 23, 2022 | The Company issued a 10% Promissory Note in the principal amount of $47,059 to Jessica Finnegan. |
| May 26, 2022 | The Company issued a 10% Promissory Note in the principal amount of $29,412 to Jessica Finnegan. |
| June 9, 2022 | The Company issued a 10% Promissory Note in the principal amount of $300,000 in a related party transaction to the Michael C. Howe Living Trust. |
| July 7, 2022 | The Company issued a 10% Promissory Note in the principal amount of $23,259 to Charles Schrier. |
| July 21, 2022 | The Company issued a 10% Promissory Note in the principal amount of $300,000 in a related party transaction to the Michael C. Howe Living Trust. |
| July 26, 2022 | The Company issued a 10% Promissory Note in the principal amount of $58,823 to Eric S. Nommsen. |
| July 27, 2022 | The Company issued a 10% Promissory Note in the principal amount of $58,823 to James H. Caplan. |
| August 4, 2022 | The Company issued a 10% Promissory Note in the principal amount of $29,412 to Jessica, Kevin C., Brody, Isabella and Jack Finnegan. |
| August 18, 2022 | The Company issued a 10% Promissory Note in the principal amount of $200,000 in a related party transaction to the Michael C. Howe Living Trust. |
| September 2, 2022 | The Company issued a 10% Promissory Note in the principal amount of $60,000 to Frank Lightmas, a 10% Promissory Note in the principal amount of $30,000 to Lisa Lewis, a 10% Promissory Note in the principal amount of $30,000 to Sharon Goff, and a 10% Promissory Note in the principal amount of $100,000 to Cliff Hagan. |
| September 15, 2022 | The Company issued a 10% Promissory Note in the principal amount of $50,000 to Mack Leath. |
| November 29, 2022 | The Company issued seven identical promissory notes in related party transactions to various individuals. |
| October 2023 | The company changed its domicile from Delaware to Nevada. |
| December 8, 2023 | The Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC. |
| October 28, 2024 | The Company filed a Certificate of Designation, Preferences and Rights of the Series A Preferred Stock with the Nevada Secretary of State. |
| December 6, 2024 | The Company entered into an Exclusive Source Code License agreement with AgingTopic, LLC. |
| December 31, 2024 | The Company entered into Obligation Exchange Agreements pursuant to which it has converted $580,132 of its 2024 Bridge Notes into Series A Preferred share. |
| January 1, 2025 | The Company shall begin the redemption of the Series A Preferred Stock. |
| Q3 FY2025 | The Robo Agent application is expected to be available for initial users. |
Keywords
common stock, debt restructuring, Series A Preferred Stock, Centcore, Vero Technology Ventures, Robo Agent, Advisory Board, going concern, financial obligations, data center services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.